HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure.

AbstractBACKGROUND:
Early glottic cancer can be cured with transoral laser resection, but in cases with anterior commissure involvement, there is still controversy concerning the best treatment modality.
METHODS:
The impact of anterior commissure involvement on local control was analyzed in a retrospective review of 444 patients with early glottic cancer (pT1a-pT2a) treated between 1986 and 2004 with transoral laser microsurgical resection.
RESULTS:
The anterior commissure was involved in 153 cases; the 5-year local control rate with and without anterior commissure involvement was 73% versus 89% for T1a and 68% versus 86% for T1b tumors. For T2a lesions, the 5-year local control rate was 76%, irrespective of anterior commissure involvement.
CONCLUSION:
In early glottic cancer treated by transoral laser microsurgery, a decrease in local control is evident in case of anterior commissure involvement for T1a and T1b but not for T2a tumors.
AuthorsRalph M W Rödel, Wolfgang Steiner, Roland M Müller, Martina Kron, Christoph Matthias
JournalHead & neck (Head Neck) Vol. 31 Issue 5 Pg. 583-92 (May 2009) ISSN: 1097-0347 [Electronic] United States
PMID19132720 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma (mortality, pathology, surgery)
  • Female
  • Glottis (surgery)
  • Humans
  • Laryngeal Neoplasms (mortality, pathology, surgery)
  • Laryngoscopy
  • Laser Therapy
  • Lasers, Gas
  • Male
  • Microsurgery
  • Middle Aged
  • Neck Dissection
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual (surgery)
  • Postoperative Complications
  • Retrospective Studies
  • Salvage Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: